Take a look at some of our customers’ favorite features in DoseMeRxhere →

Articles

All topics

Media Release

Blog

Tobramycin

Vancomycin Dosing

Press Release

Company Announcement

Events

DoseMe Exhibits at ASHP2024

DoseMe’s Dr. Sharmeen Roy Honored with the STRIPE Double Helix Award for Excellence in Advancing Pharmacogenomics through Collaboration

Webinar registration | A Baby-Stepwise Approach to AUC Dosing in Pediatrics | 10.30.24

DoseMe Expands Licensing Agreement with Dot.lib

DoseMe Achieves HITRUST Risk-Based, 2-year (r2) Certification

DoseMe Enhances Web-based User Experience and Capability to Further Scale its Precision Dosing Platform

Physiomics Adds Modeling and Data Science Functionality to DoseMe’s Precision Dosing Platform

thought leadership

How DoseMeRx is Transforming Patient Care

DoseMeRx submitted a formal application for CE certification under MDR, Ensuring Uninterrupted Service and Safety for Customers and Patients

Revolutionizing Medicine: DoseMeRx’s Journey to Smarter Dosing!

Dameron Hospital Selects DoseMeRx to Advance Precision Dosing

DoseMe Enables Precision Dosing at Independence Health System

Industry Veteran Dr. Howard McLeod Joins the DoseMe Clinical Advisory Board

DoseMe Expands Global Footprint as Premier Hospitals and Cancer Centers across Australia Continue to Adopt Bayesian Dosing

DoseMe Bioinformatician and Chief Science and Strategy Officer Co-Author Abstract Big Data Bayesian Truths to Be Covered in Oral Presentation at the 34th ECCMID Annual Meeting

Advanced Infliximab Model Now Available from DoseMe

DoseMe Partners with Albertina icome Praha as Demand for Precision Dosing in Czech and Slovakia Continues to Increase

Vancomycin dosing

DoseMe Expands Vancomycin Hemodialysis Model

DoseMe Expands Its Reseller Agreement with Primum Pharma into the MENA Market

DoseMe Fuels Global Expansion with Appointment of Siegfried Braeuer to Director International Sales

DoseMe Announces 2023 Highlights; Precision Dosing Fast-Tracking to Top Trend in 2024

DoseMe Amplifies Presence in Turkey via Distribution and Reseller Agreement with Primum Pharma

UTMB Taps DoseMe’s Genetic Biomarker Capabilities for Precision Dosing

DoseMe Adds Cefepime to Its Model-informed Precision Dosing Platform

Webinar registration | Precision Beta-lactam Dosing | 10.25.23

DoseMe Selected as a Pharma 2023 Innovation Award Winner

Sarah Bush Lincoln Adopts DoseMe Precision Dosing Platform to Improve Overall Level of Patient Care

A.C. Camargo Cancer Center Harnesses the Power of DoseMe Precision Dosing Platform to Substantially Reduce Toxicity and Kidney Injuries

DoseMe Achieves HITRUST Risk-based, 2-year Certification Demonstrating the Highest Level of Information Protection Assurance

Webinar registration | Maximizing Aminoglycoside Efficacy with AUC-guided TDM

New England Life Care Selects DoseMe to Support New Initiatives Around Compliance Protocols

DoseMe Expands Leadership Team with Appointments of Paul Edwards to CEO, John Hardesky to CCO and Sharmeen Roy to Chief Strategy & Science Officer

Bayesian Dosing of Tobramycin Outperforms Other Personalized Dosing Strategies at Pediatric Hospital

Fairlong Capital LLC acquires DoseMeRx

Webinar registration | Mastering Big Data for Therapeutic Drug Monitoring | October 25 2022

Meta-analysis supports the cost-effectiveness of Bayesian dosing software—but reinforces perceived barriers to adoption

ID Connect | Vancomycin & MRSA Pneumonia | Joint Webinar | August 16th 2022, 1pm ET

DoseMeRx and Wolters Kluwer

Wolters Kluwer | Vancomycin Bayesian Dosing | Joint Webinar | June 15th 2022, 12pm CST

Do’s and Don’ts of Bayesian Dosing | Webinar | Sep. 22, 2021, 2pm ET

2020 Vancomycin Guidelines with ASHP | Joint Webinar | May 18th 2021, 3pm ET

DoseMeRx and Wolters Kluwer

Wolters Kluwer Vancomycin AUC Dosing | Joint Webinar | May 4th 2021, 12pm CST

Infectious Disease Connect® Announces Precision Dosing Powered

Tabula Rasa HealthCare Announces Clinical Advisory Board for its Hospital Division

ASHP Partners with Tabula Rasa HealthCare’s DoseMeRx™ to Offer Bayesian Dosing Solution for Vancomycin

In Case You Missed It: IDWeek Recap

TRHC’s DoseMeRx® Partners with Physiomics to Provide Precision Dosing for Oncology Medications

DoseMeRx and Wolters Kluwer

Wolters Kluwer Targets Precision Dosing with TRHC’s DoseMeRx Integration

ASHP Midyear: Presentations You Shouldn’t Miss This Year

Neil Medical Group Selects TRHC’s DoseMeRx to Provide Precision Dosing Services For Long-term Care Facilities

DoseMeRx Achieves HITRUST CSF® Certification to Manage Risk, Improve Security Posture and Meet Compliance Requirements

New Study Finds DoseMeRx Increases Vancomycin AUC Target Attainment

Optimizing Therapy with Cyclosporine at the University Medical Centre Maribor

Tabula Rasa HealthCare’s DoseMeRx Integrates with The Sanford Guide

Tabula Rasa HealthCare Announces VigiLanz Precision Dosing Powered by DoseMeRx

DoseMe to Sponsor the 4th Annual Middle Tennessee Antimicrobial Stewardship Symposium

ASHP Midyear – DoseMeRx to Showcase Cerner & Epic Integration

DoseMe® to Provide Precision Dosing Services for St. Joseph’s/Candler

IDWeek: Optimal Vancomycin Dosing using Bayesian Method Poster Presentations

BayCare Health System to Present on Improved Pharmacy Operations using DoseMeRx at CHC2019

DoseMe Bayesian Forecasting Method Receives Rating of Most User-Friendly in Clinical Study

BayCare Health System To Showcase DoseMeRx at CHC 2019

Dr Kristi Kuper Joins DoseMe as Director of Clinical Pharmacy

Bainbridge Health Partners with DoseMe To Expand Medication Management Capabilities to Health Systems

Houston Methodist Selects DoseMe For System-wide Precision Dosing Technology

DoseMe Signs 3-Year Agreement with Portugal’s National Health Service

DoseMe Showcase at ASHP Summer Meeting 2019

DoseMe Joins Tabula Rasa HealthCare

Tabula Rasa HealthCare to Acquire DoseMe

Texas Children’s & Houston Methodist Vizient Webinar

DoseMeRx on Show at ASHP Midyear Clinical Meeting

DoseMe to Present at IATDMCT Congress 2018

University Hospitals of Leicester NHS Trust Select DoseMeRx to Optimize ICU Vancomycin Dosing

Healix Announces Strategic Partnership with DoseMe for Precision Dosing

DoseMe Selected to Showcase at 2018 BIO International Convention

DoseMe Supports 27th Annual PPAG Meeting

DoseMeRx to Be Showcased at European Association of Hospital Pharmacists Congress

DoseMe Increases FHIR Power in Epic’s App Orchard

Precision dosing set to shake up medicine

Priscilla Rogers, formally IBM Research – Australia, joins DoseMe Advisor Board

DoseMe Joins Microsoft for Healthcare Digital Innovation HISA Breakfast Series

DoseMe and Cerner – Tomorrow, Today – Cerner Health Conference 2017

DoseMe Wins Place in Inaugural ANDHealth+ Program

DoseMe to Showcase Precision Dosing Decision Support at Cerner Health Conference

DoseMe teams up with EHR vendor Cerner to deliver Precision Medicine

Healthcare has come a long way, but there’s always room for improvement

DoseMe Bets Big on Precision Dosing in USA

Antibiotic Resistance and The Right Dose, Right Drug, Right Time

A Dose of Confidence with Microsoft ASD Certification

TDI Welcomes Leading Teaching Institutions to Ever Expanding Family

DoseMe Provides Dose of Advice to Queensland’s Top Innovators at QLD iAwards

DoseMeRx ASHP Summer Debut

DoseMe set to deliver precision dosing at eHealth QLD Expo

Cash injection right medicine for DoseMe push into hospitals

Personalized Dosing – It’s here, but how do we do it?

DoseMe Partners with Microsoft

Delivering Precision Dosing to Australian Cancer Patients

DoseMe completes Series A financing, eyes global expansion

HIPAA Privacy Statement | Privacy policy | DoseMe & the GDPR | Copyright © 2012 - 2024 DoseMe Pty Ltd. All Rights Reserved.
DoseMe® is a registered trademark of DoseMe Pty Ltd. DoseMeRx℠ and DoseMe℞℠ are service marks of DoseMe LLC.